TTK Healthcare Limited (BOM:507747)
India · Delayed Price · Currency is INR 967.60
-14.45 (-1.47%)
At close: Jan 23, 2026
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.27B INR in the quarter ending December 31, 2025, with 10.74% growth. This brings the company's revenue in the last twelve months to 8.31B, up 4.96% year-over-year. In the fiscal year ending March 31, 2025, TTK Healthcare had annual revenue of 8.01B with 6.47% growth.
Revenue (ttm)
8.31B
Revenue Growth
+4.96%
P/S Ratio
1.64
Revenue / Employee
6.21M
Employees
1,339
Market Cap
13.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | 4.76B | -1.70B | -26.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Morepen Laboratories | 17.56B |
| Bliss GVS Pharma | 8.60B |
| Venus Remedies | 6.99B |
| Lincoln Pharmaceuticals | 6.32B |
| Fermenta Biotech | 5.63B |
| Syncom Formulations (India) | 5.15B |
| Amrutanjan Health Care | 4.70B |
| Kwality Pharmaceuticals | 4.23B |